NorthCrest Asset Manangement, LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1893159
PLYMOUTH, MN
Position in AMRX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$701,245
+$198,725 QoQ
Shares Held
40,511
+0.2% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#155
of 305 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NorthCrest Asset Manangement, LLC holds $8,955,398 across 8 Drug Manufacturers - Specialty & Generic names. AMRX ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
5,628 | $3,049,419 | |
| 2 | ZTS |
Zoetis Inc.
|
34,354 | $2,468,678 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,177 | $1,378,151 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
40,511 | $701,245 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
35,100 | $508,599 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
4,081 | $452,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
7,100 | $335,617 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
14,476 | $60,943 |
All Filings in AMRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $701,245 | 40,511 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $502,520 | 40,428 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $514,332 | 40,820 | Shares | Sole | 2026-01-08 | |
| No filing history on record for this holder in this stock. | ||||||